TY - JOUR
T1 - Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage
AU - Di Biase, L.
AU - Mohanty, Sanghamitra
AU - Trivedi, Chintan
AU - Romero, J.
AU - Natale, Veronica
AU - Briceno, D.
AU - Gadiyaram, Varuna
AU - Couts, L.
AU - Gianni, Carola
AU - Al-Ahmad, Amin
AU - Burkhardt, John David
AU - Gallinghouse, G. Joseph
AU - Horton, Rodney
AU - Hranitzky, Patrick M.
AU - Sanchez, Javier E.
AU - Natale, Andrea
N1 - Publisher Copyright:
© 2019 American College of Cardiology Foundation
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/8/27
Y1 - 2019/8/27
N2 - Background: Loss of contractility leading to stasis of blood flow following left atrial appendage electrical isolation (LAAEI) could lead to thrombus formation. Objectives: This study evaluated the incidence of thromboembolic events (TE) in post-LAAEI cases “on” and “off” oral anticoagulation (OAC). Methods: A total of 1,854 consecutive post-LAAEI patients with follow-up transesophageal echocardiography (TEE) performed in sinus rhythm at 6 months to assess left atrial appendage (LAA) function were included in this analysis. Results: The TEE at 6 months revealed preserved LAA velocity, contractility, and consistent A waves in 336 (18%) and abnormal parameters in the remaining 1,518 patients. In the post-ablation period, all 336 patients with preserved LAA function were off OAC. At long-term follow-up, patients with normal LAA function did not experience any stroke events. Of the 1,518 patients with abnormal LAA contractility, 1,086 remained on OAC, and the incidence of stroke/transient ischemic attack (TIA) in this population was 18 of 1,086 (1.7%), whereas the number of TE events in the off-OAC patients (n = 432) was 72 (16.7%); p < 0.001. Of the 90 patients with stroke, 84 received left atrial appendage occlusion (LAAO) devices. At median 12.4 months (interquartile range: 9.8 to 15.3 months) of device implantation, 2 (2.4%) patients were on OAC because of high stroke risk or personal preference, whereas 81 patients discontinued OAC after LAAO device implantation without any TE events. Conclusions: LAAEI is associated with a significant risk of stroke that can be effectively reduced by optimal uninterrupted OAC or LAAO devices.
AB - Background: Loss of contractility leading to stasis of blood flow following left atrial appendage electrical isolation (LAAEI) could lead to thrombus formation. Objectives: This study evaluated the incidence of thromboembolic events (TE) in post-LAAEI cases “on” and “off” oral anticoagulation (OAC). Methods: A total of 1,854 consecutive post-LAAEI patients with follow-up transesophageal echocardiography (TEE) performed in sinus rhythm at 6 months to assess left atrial appendage (LAA) function were included in this analysis. Results: The TEE at 6 months revealed preserved LAA velocity, contractility, and consistent A waves in 336 (18%) and abnormal parameters in the remaining 1,518 patients. In the post-ablation period, all 336 patients with preserved LAA function were off OAC. At long-term follow-up, patients with normal LAA function did not experience any stroke events. Of the 1,518 patients with abnormal LAA contractility, 1,086 remained on OAC, and the incidence of stroke/transient ischemic attack (TIA) in this population was 18 of 1,086 (1.7%), whereas the number of TE events in the off-OAC patients (n = 432) was 72 (16.7%); p < 0.001. Of the 90 patients with stroke, 84 received left atrial appendage occlusion (LAAO) devices. At median 12.4 months (interquartile range: 9.8 to 15.3 months) of device implantation, 2 (2.4%) patients were on OAC because of high stroke risk or personal preference, whereas 81 patients discontinued OAC after LAAO device implantation without any TE events. Conclusions: LAAEI is associated with a significant risk of stroke that can be effectively reduced by optimal uninterrupted OAC or LAAO devices.
KW - LAA function
KW - atrial fibrillation
KW - catheter ablation
KW - left atrial appendage electrical isolation
KW - left atrial appendage occlusion
KW - oral anticoagulant
KW - thromboembolic events
UR - http://www.scopus.com/inward/record.url?scp=85070489790&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070489790&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2019.06.045
DO - 10.1016/j.jacc.2019.06.045
M3 - Article
C2 - 31439209
AN - SCOPUS:85070489790
SN - 0735-1097
VL - 74
SP - 1019
EP - 1028
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 8
ER -